Aeries Technology (NASDAQ: AERT) faces Nasdaq delisting after bid price lapse
Rhea-AI Filing Summary
Aeries Technology, Inc. reported that on March 31, 2026 it received a formal notice from Nasdaq staff that its continued non-compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) could result in delisting of its securities from the Nasdaq Capital Market.
The company plans to request a hearing before the Nasdaq Hearings Panel, which would temporarily stay further Nasdaq action while the Panel reviews the case. A previous grace period to regain compliance, granted after a September 30, 2025 deficiency notice, expired on March 30, 2026 without the company restoring its bid price to required levels.
Aeries is not eligible for an additional 180‑day grace period because it does not meet the minimum stockholders’ equity requirement for initial listing on the Nasdaq Capital Market. The company states it is considering all available options but notes there is no assurance the Panel will allow its listing to continue or that it will meet listing standards within any extension granted.
Positive
- None.
Negative
- Nasdaq delisting risk: Aeries failed to regain compliance with Nasdaq’s minimum bid price rule by March 30, 2026 and also does not meet the Nasdaq Capital Market’s minimum stockholders’ equity requirement, prompting a Nasdaq staff determination on March 31, 2026 that could result in delisting of its securities.
Insights
Nasdaq delisting risk rises as Aeries misses bid price and equity tests.
Aeries Technology has moved from a routine bid-price deficiency into a more serious phase. After failing to regain compliance by March 30, 2026, Nasdaq staff issued a determination on March 31, 2026 that could lead to delisting from the Nasdaq Capital Market.
The company is ineligible for a second 180‑day cure period because it does not meet the minimum stockholders’ equity requirement for initial Nasdaq Capital Market listing. That combination of bid-price non-compliance and equity shortfall indicates broader balance sheet constraints, beyond short-term share price volatility alone.
Aeries plans to request a hearing before the Nasdaq Hearings Panel, which will stay immediate delisting while the Panel evaluates its situation. The outcome will depend on whether the company can present a credible path to meeting both the bid-price rule and equity standards within any timeline the Panel sets.